Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bary

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Therapie|November 1, 1989
[AZT in community practice]M Bary, J F Mettetal
Nature|June 15, 1978
Effect of cocultivation on sister chromatid exchange frequencies in Bloom's syndrome and normal fibroblast cellsR Tice, G Windler, J M Bary
Lancet (London, England)|January 26, 1991
Heterosexual transmission of the aetiological agent of Kaposi's sarcomaM Bary, D Vittecoq, J Y Liotier, et al.
Acta Orthopaedica Belgica|January 1, 1987
[Radiological evaluation of cup anteversion in total hip prosthesis]W Lokietek, J Legaye, J M Bary, et al.
The American Journal of Medicine|July 1, 1991
Poor tolerance of zidovudine in an HIV-asymptomatic patient with alpha-thalassemiaD Vittecoq, E Delabesse, M Bary, et al.
Medecine Et Maladies Infectieuses|March 8, 2005
[Neurospychiatric symptoms in HIV infected patients and the role of efavirenz]M Bary, F David, J Gasnault, et al.
Journal of Medical Virology|January 27, 1998
Longitudinal study of plasma HIV-1 RNA concentrations during the asymptomatic stage of HIV infection measured using AMPLICOR HIV monitor and NASBA HIV-1 RNA QT tests. ACCTES AssociationC Delamare, M Burgard, C Deveau, et al.
Journal De Pharmacie De Belgique|June 27, 2013
[Implementation of computerized phisician order entry in a hospital setting: what are the keys to success?]R Garçous, G Remy, M Bary, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|May 1, 1991
[Passive immunotherapy in AIDS: transfusion of plasma rich in anti-p25 antibody (phase I trial)]J J Lefrère, D Vittecoq, B Mattlinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 1995
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasmaD Vittecoq, S Chevret, L Morand-Joubert, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Therapie|November 1, 1989
[AZT in community practice]M Bary, J F Mettetal
Nature|June 15, 1978
Effect of cocultivation on sister chromatid exchange frequencies in Bloom's syndrome and normal fibroblast cellsR Tice, G Windler, J M Bary
Lancet (London, England)|January 26, 1991
Heterosexual transmission of the aetiological agent of Kaposi's sarcomaM Bary, D Vittecoq, J Y Liotier, et al.
Acta Orthopaedica Belgica|January 1, 1987
[Radiological evaluation of cup anteversion in total hip prosthesis]W Lokietek, J Legaye, J M Bary, et al.
The American Journal of Medicine|July 1, 1991
Poor tolerance of zidovudine in an HIV-asymptomatic patient with alpha-thalassemiaD Vittecoq, E Delabesse, M Bary, et al.
Medecine Et Maladies Infectieuses|March 8, 2005
[Neurospychiatric symptoms in HIV infected patients and the role of efavirenz]M Bary, F David, J Gasnault, et al.
Journal of Medical Virology|January 27, 1998
Longitudinal study of plasma HIV-1 RNA concentrations during the asymptomatic stage of HIV infection measured using AMPLICOR HIV monitor and NASBA HIV-1 RNA QT tests. ACCTES AssociationC Delamare, M Burgard, C Deveau, et al.
Journal De Pharmacie De Belgique|June 27, 2013
[Implementation of computerized phisician order entry in a hospital setting: what are the keys to success?]R Garçous, G Remy, M Bary, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|May 1, 1991
[Passive immunotherapy in AIDS: transfusion of plasma rich in anti-p25 antibody (phase I trial)]J J Lefrère, D Vittecoq, B Mattlinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 14, 1995
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasmaD Vittecoq, S Chevret, L Morand-Joubert, et al.
Pageof 2